Brain tumour drug quests
£1.5m ‘Quest for Cures’ grant to tackle aggressive brain tumours
An Imperial team engineering new techniques in cancer immunotherapy has been awarded £1.5m over five years.
£1.5m ‘Quest for Cures’ grant to tackle aggressive brain tumours
An Imperial team engineering new techniques in cancer immunotherapy has been awarded £1.5m over five years.
Apollo Therapeutics raises $226.5m to develop medicines based on uni research
Company founded by the tech transfer offices of Imperial, Cambridge and UCL has raised major Series C funding to turn basic research into medicines.
Research sheds light on how breast cancer might develop after pregnancy
A study observing changes in healthy breast cells may explain why breast cancer might develop after pregnancy.
Q&A: How can medical science better serve women?
Underfunding in reproductive health research, exclusion from clinical trials and misinformation mean women are being underserved by medical science.
1
Imperial Professor co-leads UK’s first womb transplant operation
After more than 25 years of research, a team co-led by Imperial’s Professor Richard Smith has performed the first womb transplant in the UK.
Study identifies vulnerable groups least likely to have COVID-19 antibodies
Findings from the MELODY study have identified which people with compromised immune systems are less likely to have COVID-19 antibodies.
Government funding to ‘revolutionise AI healthcare research'
UKRI announces £13 million funding for artificial intelligence in health, with three projects launched at Imperial College London.
New research using ‘smart’ socks could transform dementia care
A sock which combines sensors with artificial intelligence could help care staff detect agitation and prevent falls in people with dementia.
Public participants help navigate AI and data science
Members of the public co-create educational guide demystifying the role of artificial intelligence and data science in healthcare.
New scholarship programme to develop next generation of health leaders
Imperial College London and Sanofi, an innovative global healthcare company, have launched a new scholarship programme for underrepresented students.